
Vital Sign and Biochemical Data Collection Using Non-contact Photoplethysmography and the Comestai Mobile Health App: Protocol for an Observational Study.
Revolutionizing Vital Sign Monitoring: Comestai App’s Non-contact Methodology 📱💓
Discover the newest research about AI innovations in 🩺 Preventive Medicine.

Revolutionizing Vital Sign Monitoring: Comestai App’s Non-contact Methodology 📱💓

AI shows higher diagnostic accuracy and treatment recommendations than physicians, with optimal ratings at 77% vs. 67%. 🤖📊

Eli Lilly has filed lawsuits against telehealth companies for selling unapproved drugs containing tirzepatide, risking patient safety. ⚖️💊

HeartBeam and AccurKardia collaborate to improve cardiac diagnostics with advanced ECG analysis software. 📈❤️

Worcestershire Acute Hospitals NHS Trust addresses sepsis screening challenges with EPR. Sepsis remains a critical health concern. ⚠️🩺

Leidos and the University of Pittsburgh invest $10 million in AI for disease detection and management. 🤖💰

HealthMed partners with Podimetrics to enhance diabetes care. 🩺 SmartMat technology helps prevent complications in high-risk patients. 👣

Mark Cuban Cost Plus Drug Company partners with Morris & Dickson to enhance access to essential injectable medications. 💊🤝

AI in healthcare raises concerns about accountability for medical errors. Physicians face pressure to trust technology without adequate support. ⚖️🤖

UK Government and Wellcome Trust invest £600 million in a Health Data Research Service to enhance medical research access. 💰📊